Partners | 3rd mRNA Analytical Development Summit 2024

2024 Partners

Find out more about who sponsored the 3rd mRNA Analytical Development Summit.
Get in touch if you would like to and learn more about our bespoke sponsorship opportunities for 2025.

Expertise Partners

Sciex

Learn more:

Areterna

Learn more:

Areterna LLC was founded in 2023 as a wholly owned subsidiary of Synthgene Biotechnology Co., Ltd. Synthgene provides raw materials and services to support mRNA and oligonucleotide manufacturing. The company has a robust quality system and ISO9001 certification to support cGMP compliant manufacturing of mRNA raw materials that include NTPs, modified NTPs, and cap analogs. For solid-phase DNA and RNA synthesis, Synthgene offers high quality phosphonamidites to support cGMP oligo manufacturing. In addition, Synthgene offers custom analytical and process development services.

www.areterna.com

InDevR

Learn more:

Program Partner

Phenomenex

Learn more:

Innovation Partner

Waters

Learn more:

Waters Corporation, a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life,
materials, and food sciences for over 60 years. With more than 8,200 employees worldwide, Waters operates directly in 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries.

www.waters.com/nextgen/gb

3CON

Learn more:

3CON develops and manufactures high-end production systems for the leading automotive industry and its suppliers. Thinkers, courageous pioneers, obsessive solution finders as well as precise and reliable implementers (all genders): with more than 20 years of experience in the industry and a constantly alert and forward-looking eye on the demands of our customers and their challenges in the future.

www.3con.com

ATEM

Learn more:

ATEM operates at the forefront of the professional cryo-EM service industry. Leveraging our in-house cryo-EM platform, we offer a full-range service portfolio and develop unprecedented technology for demanded analytical applications in the field of small molecule, biologic- and gene-therapy centered drug design.

Our newest innovation is focused on the fully automated, cryo-EM based morphological characterization of Lipid Nano Particle (LNP) samples. Artificial Intelligence (AI) driven, our platform - for the first time world-wide - now allows us to visualize, quantify and enumerate most significant critical quality attributes (CQAs) of your LNP samples at scale, in one assay.

www.atem.bio

Eclipse Bio

Learn more:

Exhibition Partners

NIS

Learn more:

Having a clear picture of nanomedicine formulations, like vaccine, gene, and drug delivery vehicles can mitigate the risk for unexpected complications. Cryo-TEM simultaneously assesses drug encapsulation, morphology, lamellarity, impurities, integrity, and aggregation, and is a powerful, orthogonal technique in any analytical toolkit. NIS provides rapid, flexible, and cost-effective access to cryo-TEM with expert knowledge and established infrastructure to accelerate projects and gain a better understanding of your formulations.

www.nanoimagingservices.com

Boston Analytical

Learn more:

Boston Analytical is a cGMP compliant, FDA/DEA registered, ISO/IEC-17025:2017 certified analytical laboratory.

Analyzing mRNA samples is challenging due to the complexity of the Drug Substance intermediates and the final formulated LNP encapsulated Drug Product. These challenges can be even more daunting when trying to manage multiple CDMOs and CROs. Boston Analytical (BA) has rolled out a comprehensive analytical solution that provides regulatory-tested methodologies for every aspect of characterizing the purity, potency, and identity of mRNA products.

Boston Analytical strives to provide characterization services that are tailored to your mRNA manufacturing platform. Phase-appropriate qualification strategies are employed and non-cGMP in-process/scale-up optimization services offerings are available.

www.bostonanalytical.com

Pace® Life Sciences

Learn more:

Pace® Life Sciences provides a full suite of contract CMC development, clinical trials materials manufacturing, regulatory compliance, consulting, and facility support services to the pharmaceutical, biopharmaceutical, and gene therapy industries. Our network of CDMO sites consists of GMP analytical testing laboratories and manufacturing support service centers. We are dedicated to delivering the best and most reliable services with positive customer experiences across all channels of our business.

www.pacelifesciences.com

Boston BioProducts

Learn more:

Event Partner

Solvias

Learn more:

Solvias is a world leader in contract research, development and manufacturing (CRO/CDMO).

Providing integrated analytical services and solutions to the pharmaceutical, biotech and medical device industries. A comprehensive analytical testing portfolio integrates a broad range of capabilities spanning all stages of drug discovery, development and commercial release for better and safer products. Solvias also offers one of the largest proprietary ligand portfolios for catalytic transformations and a suite of related custom synthesis and catalysis technology services.

https://www.solvias.com/

Exothera

Learn more:

Exothera Nucleic Acids specializes in the production of RNA therapeutics and is the first nucleic acid CRDMO offering continuous RNA manufacturing services from early discovery up to cGMP. As a Univercells company, we benefit from access to novel DNA and RNA manufacturing technologies and best-in-class bioprocessing expertise. We are the first CRDMO to have access to new, continuous RNA manufacturing technology that enables us to rapidly produce the highest quality RNA for vaccines and therapeutics. We provide accelerated discovery services and develop processes for non-GMP and GMP production at clinical or commercial scale, faster and more reliably than previously possible.

www.exothera.world/